central drugs standard control organisation

  1. S

    India Faces Rising Threat of Substandard Medicines, AAP MP Calls for Action

    New Delhi, March 27 AAP MP Vikramjit Singh Sahney raised the issue of spurious medicines on Friday and expressed serious concerns about the growing threat of substandard and counterfeit medicines in the country.During the zero hour in the Rajya Sabha, he said the issue of manufacturing...
  2. S

    India’s Stem Cell Therapy Guidelines Tightened for Autism Care

    New Delhi, March 26 The National Medical Commission (NMC) has issued an advisory declaring stem cell therapy illegal for the treatment of Autism Spectrum Disorder in compliance with a Supreme Court order.The move is aimed at curbing illegal practices by private clinics in metropolitan and...
  3. S

    India's Pharma Sector: CDSCO Streamlines Licensing Process

    New Delhi, March 19 The Central Drugs Standard Control Organisation (CDSCO) has issued comprehensive guidelines outlining a dossier-based approach for issuing and renewing drug manufacturing licenses, aimed at ensuring uniform product licensing and quality standards.The document, released last...
  4. G

    High Court Seeks Reply on Diabetes Drugs Used for Weight Loss

    New Delhi, March 17 – The Delhi High Court issued a notice on Tuesday regarding a contempt petition alleging non-compliance with its earlier order directing the Central Drugs Standard Control Organisation (CDSCO) to examine safety and regulatory concerns regarding the use of certain diabetes...
  5. N

    Cough Syrup Manufacturing Issues Addressed Through Increased Regulatory Oversight

    Mumbai, February 23 The Central Drugs Standard Control Organisation (CDSO) has conducted an audit of almost 90 per cent of cough syrup manufacturers in the country, and it hopes to eliminate the "problem" in cough syrup by the next season, a top official said on Monday.Speaking at the 11th...
  6. D

    National Compliance Platform Discusses Risks in Sports Supplements and Pharmaceuticals

    New Delhi, February 16 Contaminated nutritional supplements, misuse of prescription medicines, and the online sale of prohibited substances were among the major points of discussion at the fourth National Compliance Platform meeting, which took place here on Monday to discuss emerging issues...
Back
Top